Augmentin (amoxicillin-clavulanate) and cephalexin are both widely prescribed oral antibiotics that belong to the broader beta-lactam family, but they differ in spectrum, side-effect profile, and the types of infections they handle best. Augmentin pairs amoxicillin with clavulanic acid, a compound that disables certain bacterial defenses, giving it reach against a wider range of organisms. Cephalexin is a first-generation cephalosporin with a narrower but reliable focus on common gram-positive bacteria. The choice between them depends less on which is “stronger” in the abstract and more on what you’re treating, what you can tolerate, and what your doctor is trying to avoid.
How Their Coverage Differs
The core distinction is breadth. Cephalexin works well against most streptococci and methicillin-susceptible staphylococci, the bacteria behind many skin infections, some urinary tract infections, and straightforward bone and joint infections. It also covers a number of common gram-negative organisms like E. coli, though its activity against gram-negatives is more limited than that of later-generation cephalosporins.
Augmentin covers all of that territory and then some. The clavulanic acid component lets it overcome beta-lactamase enzymes that many bacteria produce to chew up plain amoxicillin or cephalexin. A comparative review of oral cephalosporins and amoxicillin-clavulanate found that cephalexin was among the least potent options with the narrowest spectrum against the pathogens tested, while amoxicillin-clavulanate was the most active against Streptococcus pneumoniae, including most strains that resist penicillin, and was also among the most potent against methicillin-susceptible Staphylococcus aureus.1PubMed. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate That broader coverage is why Augmentin tends to be the go-to for infections where resistant organisms are a realistic concern, such as sinus infections, certain ear infections, and bite wounds.
Skin and Soft Tissue Infections
For simple cellulitis without abscess, both drugs generally work. This is one area where the narrower spectrum of cephalexin is actually an advantage: if the infection is likely caused by garden-variety strep or staph, there’s little reason to use a broader agent. A study comparing beta-lactam antibiotics to MRSA-targeted antibiotics for simple cellulitis found no significant difference in treatment failure rates even after the rise of community-acquired MRSA.2PubMed. Comparison of initial antibiotic choice and treatment of cellulitis in the pre- and post-community-acquired methicillin-resistant Staphylococcus aureus eras In other words, for straightforward skin infections without pus pockets, cephalexin remains a reasonable first pick, and reaching for Augmentin’s broader spectrum doesn’t offer a clear benefit.
When the infection involves a bite wound from an animal or a human, the calculus changes. Bite wounds introduce a mix of aerobic and anaerobic bacteria from the mouth, and Augmentin’s anaerobic coverage handles that mix in a way cephalexin cannot. Most guidelines point to Augmentin as the first-line oral option for bite-wound prophylaxis and treatment for exactly that reason.
Urinary Tract Infections
Neither Augmentin nor cephalexin is a first-line choice for a routine uncomplicated UTI in a healthy adult. Nitrofurantoin and trimethoprim-sulfamethoxazole are preferred in most guidelines because they concentrate well in urine and carry lower resistance concerns. But both Augmentin and cephalexin are used for UTIs when first-line options aren’t suitable, or in specific populations like pregnant women.
A comparative trial of both drugs in pregnant women with bacteriuria found similar cure rates at two weeks: about 77% for amoxicillin-clavulanate and 74% for cephalexin. At six weeks, the gap widened somewhat (76% vs. 60%), though the difference was not statistically significant. Even when only ampicillin-resistant infections were counted, cure rates remained comparable in the short term, though cephalexin’s six-week cure rate dropped further.3PubMed Central. Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy The takeaway is that for UTIs in pregnancy, both can work, but Augmentin may hold up better over time when resistance is a factor.
Ear Infections and Sinusitis
Augmentin has a clear edge for acute otitis media (middle ear infections) and bacterial sinusitis. Both conditions are commonly caused by S. pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The last two frequently produce beta-lactamase, which makes plain amoxicillin and cephalexin less reliable against them. High-dose Augmentin (using the amoxicillin component at 90 mg/kg/day in children or 2 g twice daily in adults) is a standard recommendation when first-line amoxicillin fails or when resistant organisms are suspected. Cephalexin has essentially no role in treating sinusitis or otitis media because its activity against the key respiratory pathogens is too limited.
Gastrointestinal Side Effects
This is where the two drugs diverge most noticeably from a patient’s day-to-day experience. Augmentin is well known for causing diarrhea, nausea, and stomach upset. The culprit is the clavulanic acid component, which irritates the gut lining and disrupts the normal balance of intestinal bacteria. Estimates vary, but diarrhea occurs in roughly one in five people taking Augmentin, and that rate climbs with higher doses. Some formulations (like the extended-release tablet) were specifically designed to reduce the clavulanate-to-amoxicillin ratio and cut down on GI symptoms.
Cephalexin causes GI side effects too, but at lower rates. Nausea and diarrhea happen, though most people tolerate cephalexin without much trouble. If you’ve been prescribed Augmentin and diarrhea is a recurring problem, switching to cephalexin (when the infection allows it) is a common clinical move precisely because of the milder GI profile.
Liver Safety
One risk that rarely makes it into casual conversation about Augmentin is liver injury. The clavulanic acid component is associated with drug-induced liver injury (DILI) at a rate that, while still uncommon, is considerably higher than that of most oral antibiotics. A large epidemiological review using UK medical records identified amoxicillin-clavulanate as having a rate of liver injury above 10 per 100,000 users, placing it in a risk tier well above plain amoxicillin, which the same study classified as relatively safe.4Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom
More recent data puts the distinction in sharper terms. Amoxicillin-clavulanate accounts for an estimated 13% to 23% of all drug-induced liver injury cases and is the leading cause of hospitalizations for adverse liver events among antibiotics. The risk is tied specifically to the clavulanic acid: the combination carries a 5- to 9-fold increase in liver injury risk compared with amoxicillin alone.5Journal of Antimicrobial Chemotherapy. Hepatic safety of antibiotics used in primary care Cephalexin does not carry this specific concern. For someone with a history of liver problems or a previous episode of drug-induced liver injury, that difference is clinically meaningful and worth discussing with a prescriber.
Risk of Clostridioides difficile Infection
C. difficile is a bacterium that can flourish in the gut when antibiotics knock out competing flora, causing severe diarrhea and colitis. Not all antibiotics raise the risk equally, and the gap between Augmentin and cephalexin here is substantial. A case-control study of community-associated C. difficile infection found that amoxicillin-clavulanate carried an adjusted odds ratio in the range of about 8 to 12, grouped with later-generation cephalosporins. First-generation cephalosporins like cephalexin, by contrast, had odds ratios between roughly 2 and 3.5, landing in a lower-risk tier alongside drugs like ampicillin and levofloxacin.6PubMed Central. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study Both carry some risk (any antibiotic can), but Augmentin’s broader disruption of gut bacteria translates into a meaningfully higher chance of triggering C. difficile.
This is one reason clinicians try to reserve Augmentin for situations that genuinely demand its broader coverage. In older adults, people with recent hospital stays, or anyone with a prior C. difficile episode, the lower gut disruption of cephalexin becomes a practical advantage.
Pregnancy and Breastfeeding
Both antibiotics are generally considered compatible with pregnancy and lactation. They are both classified in ways that reflect decades of clinical use without major signals of fetal harm. The UTI trial in pregnant women described earlier is one example of both drugs being used safely in that population.
In breastfeeding, a study compared infant side effects in mothers taking amoxicillin-clavulanate versus a control group on amoxicillin alone, and separately compared cefuroxime to a control group on cephalexin. In the amoxicillin-clavulanate group, about 22% of infants had minor adverse effects (mostly skin rash and loose stools), and the rate increased with higher doses. In the amoxicillin-only control group, about 7.5% of infants had adverse effects. All reactions were mild and self-limiting, and none required stopping breastfeeding.7Therapeutic Drug Monitoring. The Safety of Amoxicillin/Clavulanic Acid and Cefuroxime During Lactation Cephalexin served as the control antibiotic in that study, meaning the researchers considered it safe enough at baseline to measure others against. The practical message: both are used during breastfeeding, but cephalexin is the gentler option if you’re concerned about minor infant symptoms like loose stools.
Dosing Schedules
Both drugs have relatively short half-lives, which means they need to be taken multiple times a day. Standard adult dosing for cephalexin is typically 250 to 500 mg two to four times daily, depending on the infection. Augmentin dosing varies more based on formulation: the standard-strength tablet (500/125 mg or 875/125 mg) is usually taken two to three times daily, while the extended-release form (2000/125 mg) is twice daily.
In children, the frequency question gets more attention. Pharmacokinetic analysis has suggested that three-times-daily dosing should be considered for both amoxicillin-clavulanate and cephalexin in pediatric infections like pyelonephritis, because the short half-lives of these drugs may not maintain adequate levels with less frequent dosing.8Journal of the Pediatric Infectious Diseases Society. Shedding Light on Amoxicillin, Amoxicillin-clavulanate, and Cephalexin Dosing in Children from a Pharmacist’s Perspective Neither drug is a once-a-day option, which is worth knowing if you’re comparing convenience to alternatives like cefdinir.
Taste in Pediatric Suspensions
Anyone who has tried to get a toddler to take an antibiotic suspension knows that palatability matters. In a study of medical residents who tasted common pediatric antibiotic liquids, amoxicillin was rated the most preferable and amoxicillin-clavulanate the least preferable.9PubMed Central. Taste Perceptions of Common Pediatric Antibiotic Suspensions and Associated Prescribing Patterns in Medical Residents Cephalexin fell somewhere in between. The clavulanic acid in Augmentin adds a bitter edge that children often resist, and this can be a real barrier to completing a full course. If a child’s infection is treatable with either drug, the taste difference is a legitimate factor in the prescribing decision, not just a trivial preference.
Cost Considerations
Augmentin is generally more expensive than cephalexin, though the size of the gap depends on your country, insurance, and which generic version you’re getting. A price analysis of antibiotics prescribed for dental care in India illustrated this clearly: a seven-day course of amoxicillin-clavulanate (500/125 mg three times daily) using the most expensive available brand cost about 798 rupees, whereas cephalexin (500 mg four times daily) cost about 535 rupees for the priciest brand and 277 rupees for the cheapest. Even the cheapest amoxicillin-clavulanate brand was substantially pricier than its plain amoxicillin equivalent.10PubMed Central. Wide Cost Variations Observed in Antibiotics and Analgesics Prescribed for Dental Care in India: A Price and Affordability Analysis In the United States, both are available as generics and are relatively affordable, but Augmentin still tends to cost more per course, and cost differences can add up when insurance coverage is thin.
Cross-Reactivity With Penicillin Allergy
Because Augmentin is built on amoxicillin, it is a penicillin. If you have a confirmed penicillin allergy, Augmentin is off the table. Cephalexin is a cephalosporin, which has a different core structure. The old teaching that about 10% of penicillin-allergic patients will also react to cephalosporins has been substantially revised downward in recent years. Current evidence puts the true cross-reactivity rate for first-generation cephalosporins like cephalexin at somewhere around 1% to 2%, and the overlap is driven more by shared side chains on specific molecules than by the beta-lactam ring they all share. Many allergists now consider cephalexin a reasonable option for patients with mild, non-severe penicillin allergies, especially after formal allergy testing. Still, anyone with a history of a severe penicillin reaction (anaphylaxis, throat swelling, hives with breathing difficulty) should have an allergist evaluate the safety of any cephalosporin before taking one.
Veterinary Use
Both drugs show up frequently in veterinary medicine, especially for dogs with skin infections. A study of prescribing practices among primary-care veterinarians found that amoxicillin-clavulanate and cephalexin were among the most commonly prescribed antibiotics for bacterial pyoderma (skin infections) in dogs.11PubMed Central. Prescribing practices of primary-care veterinary practitioners in dogs diagnosed with bacterial pyoderma If your vet has prescribed one of these for your pet, the logic mirrors the human picture: cephalexin is often the default for straightforward staph-driven skin infections, while amoxicillin-clavulanate gets chosen when a broader or more resistant organism is suspected. The liquid suspension taste issue matters here too, since dogs and cats given Augmentin liquid may refuse it more readily than cephalexin.
When One Clearly Beats the Other
Despite overlapping coverage, there are infections where the choice is essentially made for you:
- Bite wounds: Augmentin is the standard oral choice because it covers the anaerobic mouth bacteria that cephalexin misses.
- Sinusitis or otitis media after amoxicillin failure: Augmentin (usually high-dose) is the recommended step-up. Cephalexin has no meaningful role here.
- Simple cellulitis without abscess: Cephalexin is a perfectly reasonable first-line pick and avoids the broader side-effect profile of Augmentin.
- Uncomplicated skin infections in patients with prior C. difficile: Cephalexin’s lower C. difficile risk makes it the safer bet.
- Patients with liver disease or prior drug-induced liver injury: Cephalexin avoids the hepatotoxicity concern tied to clavulanic acid.
For many common outpatient infections, both drugs are reasonable options and the decision comes down to individual factors: allergy history, past GI tolerance, cost, and what specific bacteria the prescriber suspects. The idea that Augmentin is universally “stronger” is a simplification. It covers more ground, but broader coverage comes with broader side effects, and for infections that sit squarely within cephalexin’s range, the narrower drug is often the smarter pick.